is there a shortage of tirzepatide FDA says the weight-loss drug over FDA: Shortage of Weight Loss
Description
A licensed provider ensures that you are a good candidate for the medication, monitors your progress, and adjusts your dosage as needed to balance efficacy with side effects
There is no established causal link between Mounjaro (tirzepatide) and increased yeast infection risk
This is why ongoing treatment is recommended for sustained results

If its not deemed suitable for you, our team will identify an alternative weight loss plan that is more suitable